VarCov Co’s Medpace MEDP Stock Holding History

VarCov Co’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,676	Closed	-$805K	–	479
2026 Q1	$805K	Buy	+1,676	New	+$858K	0.3%	121

Other funds holding MEDP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

VarCov Co's MEDP Position: Q2 2026 in Review

VarCov Co sold out of Medpace (MEDP) in Q2 2026, closing a stake of 1,676 shares — an estimated $805K sold.

VarCov Co first reported a position in MEDP in Q1 2026 and held it in 1 quarter. The position peaked at $805K in Q1 2026. 693 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

VarCov Co reported no remaining Medpace position as of Q2 2026 after selling out during the quarter.
VarCov Co sold 1,676 Medpace shares in Q2 2026, an estimated $805K.
VarCov Co first reported a position in Medpace in Q1 2026 and held it in 1 quarter.
VarCov Co's Medpace position peaked at $805K in Q1 2026.
693 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on VarCov Co's 13F filing for Q2 2026, filed 14 Aug 2026.